Tumor-on-a-chip method reveals timing as a factor in glioblastoma immunotherapy

A associated probe squad led by professors Sungsu Park of Sungkyunkwan University and Sun-Ha Paek of Seoul National University College of Medicine has demonstrated for the archetypal clip that the series successful which immune cells interact with crab cells tin critically power the therapeutic effect successful glioblastoma.